| abstract |
The invention relates to compounds of formula (I), which are xanthine derivatives, methods for producing said derivatives, pharmaceutical compositions containing these compounds, and the use of compounds in therapy, for example, in the treatment of diseases in which preactivation of the HM74A receptor could have an effect on the disease or in which activation of the receptor will be effective. |